Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database

Similar Items

• Trends of reporting of ‘serious’vs. ‘non-serious’ adverse drug reactions over time: a study in the French PharmacoVigilance Database
  od: Moulis, Guillaume, i dr.
  Izdano: (2012)
• Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol)
  od: Tavassoli, Neda, i dr.
  Izdano: (2009)
• Drugs and dilated cardiomyopathies: a case/noncase study in the French PharmacoVigilance Database
  od: Montastruc, Guillaume, i dr.
  Izdano: (2010)
• Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database
  od: Berthet, Stephanie, i dr.
  Izdano: (2011)
• Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
  od: Montastruc, Jean-Louis, i dr.
  Izdano: (2020)